✦ LIBER ✦

Validation study of a prognostic classification in patients with metastatic colorectal cancer who received irinotecan-based second-line chemotherapy

✍ Scribed by Shitara, Kohei; Yuki, Satoshi; Yamazaki, Kentaro; Naito, Yoichi; Fukushima, Hiraku; Komatsu, Yoshito; Yasui, Hirofumi; Takano, Toshimi; Muro, Kei

Book ID: 120087135
Publisher: Springer-Verlag
Year: 2012
Tongue: English
Weight: 251 KB
Volume: 139
Category: Article
ISSN: 1432-1335
DOI: 10.1007/s00432-012-1349-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcomes of irinotecan-based chemotherap

Outcomes of irinotecan-based chemotherapy regimens in elderly medicare patients with metastatic colorectal cancer

✍ Nour A. Obeidat; Françoise G. Pradel; Ilene H. Zuckerman; Sylvain DeLisle; C. Da 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Analysis of Prognostic Factors and Appli

Analysis of Prognostic Factors and Applicability of Köhne's Prognostic Groups in Patients with Metastatic Colorectal Cancer Treated with First-Line Irinotecan or Oxaliplatin-Based Chemotherapy

✍ Roberto Díaz; Jorge Aparicio; Regina Gironés; Jorge Molina; Laura Palomar; Angel 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 886 KB

Multicenter phase II study of irinotecan

Multicenter phase II study of irinotecan as second line chemotherapy in metastatic colorectal cancer after prior exposure to infusional 5-FU based chemotherapy

✍ Schöffski, P.; Vanhoefer, U.; Kirchner, H.; Trenn, G.; Bokemeyer, C.; Preusser, 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Phase I study of bevacizumab combined wi

Phase I study of bevacizumab combined with irinotecan and S-1 as second-line chemotherapy in patients with advanced colorectal cancer

✍ Hitoshi Kusaba, Taito Esaki, Junji Kishimoto… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 179 KB

UGT1A1 genotyping for irinotecan-based c

UGT1A1 genotyping for irinotecan-based chemotherapy in the first-line treatment for metastatic colorectal cancer patients with hyperbilirubinemia: Report of cases

✍ Yeh, Yung-Sung; Wu, Ming-Xia; Huang, Meng-Lin; Chang, Se-Fen; Chen, Chin-Fan; Hu 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 185 KB

Effects of bevacizumab on plasma concent

Effects of bevacizumab on plasma concentration of irinotecan and its metabolites in advanced colorectal cancer patients receiving FOLFIRI with bevacizumab as second-line chemotherapy

✍ Yosuke Horita; Y. Yamada; Y. Hirashima; K. Kato; T. Nakajima; T. Hamaguchi; Y. S 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 529 KB